GlassScriptPhysician profile
Martina M Mcgrath
NPI 1679701270
$13,778.52
in general payments reported to CMS, 2019-2025
5 companies · $3,578 in 2025
The $3,578 reported for 2025 was more than what 92% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $10K · 2025: $3,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,837 · Consulting Fee: $3,480 · Food and Beverage: $361 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,836.62 |
| Consulting Fee | $3,480.00 |
| Food and Beverage | $360.77 |
| Education | $101.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $12,207.39 | 2024-2025 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $1,470.00 | 2025 | |
| Novo Nordisk INC | $96.81 | 2025 | Rivfloza |
| Travere Therapeutics, INC. | $4.32 | 2024-2025 | Filspari |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martina Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.